<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03465501</url>
  </required_header>
  <id_info>
    <org_study_id>BOOST-CA IPC 2017-016</org_study_id>
    <nct_id>NCT03465501</nct_id>
  </id_info>
  <brief_title>Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates</brief_title>
  <acronym>BOOST-CA</acronym>
  <official_title>Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting
      [low dose rate (LDR) and high dose rate (HDR)]
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate, Tolerance
      of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 17, 2007</start_date>
  <completion_date type="Actual">July 28, 2016</completion_date>
  <primary_completion_date type="Actual">July 28, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the efficacy of interstitial brachytherapy of the anal canal</measure>
    <time_frame>1 year</time_frame>
    <description>Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the tolerance of interstitial brachytherapy of the anal canal</measure>
    <time_frame>1 year</time_frame>
    <description>Tolerance of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimation of local control</measure>
    <time_frame>1 year</time_frame>
    <description>Local control defined as the time between the date of diagnosis and the date of local relapse or death or recent news</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of disease free survival</measure>
    <time_frame>1 year</time_frame>
    <description>Disease free survival defined as the delay between the date of diagnosis and the date of local or locoregional or distant relapse or death or recent news</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of overall survival</measure>
    <time_frame>1 year</time_frame>
    <description>Overall survival defined as the time between the date of diagnosis and the date of death or latest news</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the incidence of toxicities (CTCAE v4) between the 2 groups</measure>
    <time_frame>1 year</time_frame>
    <description>rate of toxicities</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">89</enrollment>
  <condition>Anal Canal Cancer</condition>
  <arm_group>
    <arm_group_label>Low Dose Rate</arm_group_label>
    <description>Patients treated with brachytherapy at low dose rate of the anal canal with aim of boost</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose Rate</arm_group_label>
    <description>Patients treated by brachytherapy with a high dose rate of the anal canal aiming for boost</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Brachytherapy</intervention_name>
    <description>Brachytherapy</description>
    <arm_group_label>Low Dose Rate</arm_group_label>
    <arm_group_label>High Dose Rate</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with anal canal brachytherapy for boost, between 2008 and 2016.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients treated by brachytherapy anal canal to boost.

        Exclusion Criteria:

          -  Patients below age of 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Leonel VARELA GAGETTI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli-Calmettes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <state>Bouches Du Rhone</state>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Cordoba A, Escande A, Leroy T, Mirabel X, Coche-Dequ√©ant B, Lartigau E. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers. Brachytherapy. 2017 Jan - Feb;16(1):230-235. doi: 10.1016/j.brachy.2016.07.007. Epub 2016 Sep 3.</citation>
    <PMID>27600606</PMID>
  </results_reference>
  <results_reference>
    <citation>Boukhelif W, Ferri-Molina M, Mazeron R, Maroun P, Duhamel-Oberlander AS, Dumas I, Martinetti F, Guemnie-Tafo A, Chargari C, Haie-Meder C. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis. Brachytherapy. 2015 Jul-Aug;14(4):549-53. doi: 10.1016/j.brachy.2015.03.006. Epub 2015 Apr 29.</citation>
    <PMID>25935731</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2018</study_first_submitted>
  <study_first_submitted_qc>March 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anal Canal Cancer</keyword>
  <keyword>brachytherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anus Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

